Literature DB >> 18985055

Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia.

Eloy Cuadrado1, Anna Rosell, Maria Borrell-Pagès, Lidia García-Bonilla, Mar Hernández-Guillamon, Arantxa Ortega-Aznar, Joan Montaner.   

Abstract

Matrix metalloproteinases (MMPs) have been implicated in the pathophysiology of ischemic stroke. In this study, we investigated the time course of gelatinolytic activation in a rat model of permanent ischemia. We observed an activation of MMPs as early as 30 mins after the ischemic insult, mainly in the nuclei of brain cells. Besides, we explored MMP-13 expression in brain samples of the animal model and stroke deceased patients. We observed an upregulation of active MMP-13 in rat brains (P<0.05) after 90 mins of cerebral ischemia. Human infarct/periinfarct samples also showed higher levels of active MMP-13 (P<0.05) compared with contralateral ones. Interestingly, we found that MMP-13 colocalized with 46-diamidino-2-phenyl indole signal by immunohistochemistry in both humans and rats, suggesting an intranuclear localization for MMP-13. Immunohistochemistry also revealed that MMP-13 was mainly produced by neurons, in both species, but also by oligodendrocytes in rats, and by astrocytes in humans. Finally we subjected a rat primary neuronal culture to oxygen and glucose deprivation (OGD) and we reproduced the nuclear translocation of MMP-13 in vitro. Nuclear extracts from cells confirmed upregulation of active MMP-13 after OGD (P<0.05). These results suggest that MMP-13 activation and its nuclear translocation is an early consequence of an ischemic stimulus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985055     DOI: 10.1038/jcbfm.2008.130

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  26 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

2.  Mild hypothermia protects against oxygen glucose deprivation (OGD)-induced cell death in brain slices from adult mice.

Authors:  Mar Hernández-Guillamon; Laura Ortega; Cristina Merino-Zamorano; Mireia Campos-Martorell; Anna Rosell; Joan Montaner
Journal:  J Neural Transm (Vienna)       Date:  2013-09-14       Impact factor: 3.575

3.  Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia.

Authors:  Yi Yang; Eduardo Candelario-Jalil; Jeffrey F Thompson; Eloy Cuadrado; Eduardo Y Estrada; Anna Rosell; Joan Montaner; Gary A Rosenberg
Journal:  J Neurochem       Date:  2009-10-15       Impact factor: 5.372

4.  Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke.

Authors:  Yingqian Zhang; Feng Fan; Guojun Zeng; Linlin Zhou; Yinbing Zhang; Jie Zhang; He Jiao; Ting Zhang; Dan Su; Cheng Yang; Xin Wang; Kai Xiao; Hongxia Li; Zhihui Zhong
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 5.  Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.

Authors:  Reid G Hendry; Leanne M Bilawchuk; David J Marchant
Journal:  J Cardiovasc Transl Res       Date:  2014-01-01       Impact factor: 4.132

6.  Citrate synthase is a novel in vivo matrix metalloproteinase-9 substrate that regulates mitochondrial function in the postmyocardial infarction left ventricle.

Authors:  Lisandra E de Castro Brás; Courtney A Cates; Kristine Y DeLeon-Pennell; Yonggang Ma; Rugmani Padmanabhan Iyer; Ganesh V Halade; Andriy Yabluchanskiy; Gregg B Fields; Susan T Weintraub; Merry L Lindsey
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

7.  Increased metalloproteinase activity in the hippocampus following status epilepticus.

Authors:  Deepti Dubey; Paulette A McRae; Elyse K Rankin-Gee; Esther Baranov; Luke Wandrey; Stephanie Rogers; Brenda E Porter
Journal:  Epilepsy Res       Date:  2017-03-01       Impact factor: 3.045

Review 8.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

Review 9.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

Review 10.  Synaptic circuit remodelling by matrix metalloproteinases in health and disease.

Authors:  George W Huntley
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.